JP Morgan Chase
CLMT icon

JP Morgan Chase’s Calumet Specialty Products CLMT Stock Holding History

JP Morgan Chase’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423K Buy
+11,800
New +$397K ﹤0.01% 5211

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase's CLMT Position: Q2 2026 in Review

JP Morgan Chase reduced its Calumet Specialty Products (CLMT) stake by 42% in Q2 2026, selling an estimated $8.15M and leaving 338,696 shares worth $12.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2635.

JP Morgan Chase first reported a position in CLMT in Q2 2013 and has held it in 49 quarters since. The position peaked at $60.8M in Q2 2013. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • JP Morgan Chase held 338,696 shares of Calumet Specialty Products worth $12.3M as of Q2 2026.
  • JP Morgan Chase sold 242,441 Calumet Specialty Products shares in Q2 2026, an estimated $8.15M.
  • Calumet Specialty Products made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2635 holding.
  • JP Morgan Chase first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 49 quarters since.
  • JP Morgan Chase's Calumet Specialty Products position peaked at $60.8M in Q2 2013.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.